Coronary artery disease Trials in Washington D.c., United States
Conditions / Coronary artery disease / Washington D.c., United States
Research into Coronary artery disease spans multiple therapeutic approaches and trial phases.
63 total trials for this combination
Showing top 10 of 63 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | TERMINATED | PHASE3 |
| NCT01442038 | Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) | COMPLETED | PHASE3 |
| NCT00977938 | The Dual Antiplatelet Therapy Study (DAPT Study) | COMPLETED | PHASE4 |
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | COMPLETED | PHASE4 |
| NCT03815175 | XIENCE 28 USA Study | COMPLETED | NA |
| NCT01275092 | Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI) | COMPLETED | PHASE2 |
| NCT02389946 | Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions | COMPLETED | NA |
| NCT00627029 | Evaluation of Programs of Coordinated Care and Disease Management | UNKNOWN | NA |
| NCT01917682 | Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions | COMPLETED | — |
| NCT01524276 | Product Surveillance Registry | RECRUITING | — |